Literature DB >> 11929036

Chemotherapy related fatal neurotoxicity during induction in acute lymphoblastic leukemia.

Munni Ray1, R K Marwaha, Amita Trehan.   

Abstract

Neurotoxicity is a common complication during cancer chemotherapy. It is estimated that 3-10% of children with acute lymphoblastic leukemia (ALL) experience acute, transient neurotoxicity during induction chemotherapy. Fatal acute neurotoxicity is rarely encountered. Neurological evaluation of children with ALL at diagnosis and during treatment is of value in order to diagnose neurological complications early so that appropriate intervention can be adopted. This communication describes the profile of two children with unexpected, acute fatal neurologic toxicity during induction chemotherapy for ALL.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11929036     DOI： 10.1007/BF02859383

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  17 in total

1.  Oculomotor nerve palsy associated with vincristine treatment.

Authors:  T Soysal; B Ferhanoğlu; M Bilir; N Akman
Journal:  Acta Haematol       Date:  1993       Impact factor: 2.195

2.  Vincristine-induced neuropathy. A clinical study of fifty leukemic patients.

Authors:  S G Sandler; W Tobin; E S Henderson
Journal:  Neurology       Date:  1969-04       Impact factor: 9.910

3.  In vivo modulation of vincristine-induced neurotoxicity in Lymnaea stagnalis, by the ACTH(4-9) analogue Org 2766.

Authors:  B Kiburg; C Moorer-van Delft; J J Heimans; P C Huijgens; H H Boer
Journal:  J Neurooncol       Date:  1996-12       Impact factor: 4.130

4.  Transient cortical blindness secondary to vincristine therapy in childhood malignancies.

Authors:  R L Byrd; T M Rohrbaugh; R B Raney; D G Norris
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

5.  Neurological complications of childhood leukaemia.

Authors:  R H Campbell; W C Marshall; J M Chessells
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

6.  A prospective cohort study of the orofacial effects of vincristine neurotoxicity.

Authors:  G M McCarthy; J R Skillings
Journal:  J Oral Pathol Med       Date:  1991-08       Impact factor: 4.253

Review 7.  Neurologic complications of chemotherapy.

Authors:  D R Macdonald
Journal:  Neurol Clin       Date:  1991-11       Impact factor: 3.806

8.  Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia.

Authors:  N J Winick; W P Bowman; B A Kamen; E S Roach; N Rollins; D Jacaruso; G R Buchanan
Journal:  J Natl Cancer Inst       Date:  1992-02-19       Impact factor: 13.506

9.  Acute mental status changes in children with systemic cancer.

Authors:  F J DiMario; R J Packer
Journal:  Pediatrics       Date:  1990-03       Impact factor: 7.124

10.  Gangliosides attenuate vincristine neurotoxicity on dorsal root ganglion cells.

Authors:  H Houi; S Mochio; T Kobayashi
Journal:  Muscle Nerve       Date:  1993-01       Impact factor: 3.217
View more
  3 in total

Review 1.  Neurologic complications of chemotherapy for children with cancer.

Authors:  Alyssa T Reddy; Kerry Witek
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Vincristine induced neurotoxicity in cancer patients.

Authors:  Sunil Gomber; Pooja Dewan; Devender Chhonker
Journal:  Indian J Pediatr       Date:  2010-01       Impact factor: 1.967

3.  Hyperleukocytosis-induced stroke and tonsillar herniation: Case report.

Authors:  Hasan Hashem; Baha'eddin A Muhsen
Journal:  Ann Med Surg (Lond)       Date:  2021-09-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.